HCL Tech Share Price Live Updates: HCL Tech's robust returns reflect market confidence
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Economic Times
17 hours ago
- Economic Times
Market Wrap: Sensex jumps 317 points, Nifty reclaims 25,150 as cooling inflation breaks 4-day D-Street slide
Sectoral Watch Live Events Expert Views Global Markets Crude Impact Rupee vs Dollar (You can now subscribe to our (You can now subscribe to our ETMarkets WhatsApp channel Indian benchmark Sensex and Nifty indices rebounded on Tuesday, snapping a four-day losing streak, as a softer-than-expected domestic inflation print buoyed market sentiment. Gains were seen across most sectors, although a weak margin outlook from HCL Tech tempered the overall Sensex rose 317.45 points, or 0.39%, to close at 82,570.91 while the Nifty 50 gained 113.50 points, or 0.45%, to settle at 25,195.80. The rebound follows a sharp pullback over the previous four sessions, during which both indices had shed nearly 1.7%.The market capitalization of all listed companies on the BSE increased by Rs 1.77 lakh crore to Rs 460.37 lakh of Sun Pharma Bajaj Finserv , Mahindra & Mahindra, and Bajaj Finance were among the top gainers on the Sensex, rising between 1% and 2.7%.All key sectoral indices ended higher on the day, with broad-based participation extending to the broader markets, both the Nifty Midcap 100 and Nifty Smallcap 100 indices advanced around 1% annual retail inflation eased to a more than six-year low of 2.10% in June, hovering near the lower end of the Reserve Bank of India's target range. The sharp decline, driven by softening food prices, has strengthened the case for potential interest rate are now focused on the U.S. inflation data, due later in the day, for cues on the Federal Reserve's rate individual stocks, Sun Pharma jumped 2.7% following expectations that its newly launched anti-baldness drug, Leqselvi, in the U.S. would support sales growth. Yes Bank surged 2.4% after Bloomberg reported that Japan's Sumitomo Mitsui Financial Group is in talks to invest $1.1 billion in the lender for an additional 5% the downside, HCL Tech slipped 3.3%, making it the worst performer on both the Nifty 50 and among IT peers, after the company posted weaker-than-expected quarterly earnings and cut its full-year margin sentiment is showing signs of improvement, supported by a blend of global and domestic developments and optimism is growing around the possibility of an interim trade agreement with the U.S., which could lead to a moderation in tariff-related risks, said Vinod Nair, Head of Research, Geojit drew comfort from the further easing of CPI inflation, which triggered notable buying in rate-sensitive sectors in hopes of a potential rate cut, said Ajit Mishra, SVP, Research at Religare Broking."However, continued disappointment from the IT space, following HCL Technologies' results, capped overall momentum. With the hurdle at the short-term moving average (20 DEMA) near 25,250 still intact, we suggest maintaining a cautious stance on the index and adopting a selective approach on the sectoral front," said equities advanced on Tuesday as investors entered a pivotal week for U.S. earnings, inflation data, and trade developments with cautious optimism.U.S. President Donald Trump over the weekend threatened to impose 30% tariffs on the EU and Mexico from August 1, up from the 20% proposed in April. However, markets found some relief after Trump signaled openness to further negotiations before the levies take world share index edged up 0.16%, nearing last week's record highs. Europe's STOXX 600 rose 0.2%, lagging behind Asia-Pacific markets, where MSCI's ex-Japan index climbed 1%. Nasdaq futures gained 0.6% after Nvidia announced plans to resume sales of its H20 chips in Asia, China's economy showed better-than-expected resilience in Q2 despite U.S. trade commodities, gold rose 0.5% to $3,361 per ounce, while silver added 0.3% to $38.25 after hitting its highest level since September prices held steady on Tuesday as U.S. President Donald Trump's 50-day ultimatum for Russia to end the war in Ukraine and avoid further sanctions helped ease immediate concerns over supply crude inched up 8 cents, or 0.12%, to $69.29 a barrel by 0931 GMT, while U.S. West Texas Intermediate (WTI) rose 3 cents, or 0.04%, to $ Indian rupee strengthened 0.2% on Tuesday to close at 85.81 against the U.S. dollar, supported by gains in most Asian currencies as the dollar weakened ahead of a key U.S. inflation report expected to offer clues on the Federal Reserve's policy dollar index, which measures the greenback against six major currencies, slipped 0.11% to 97.97.(With inputs from agencies)
Time of India
17 hours ago
- Time of India
Market Wrap: Sensex jumps 317 points, Nifty reclaims 25,150 as cooling inflation breaks 4-day D-Street slide
Indian benchmark Sensex and Nifty indices rebounded on Tuesday, snapping a four-day losing streak, as a softer-than-expected domestic inflation print buoyed market sentiment. Gains were seen across most sectors, although a weak margin outlook from HCL Tech tempered the overall advance. The Sensex rose 317.45 points, or 0.39%, to close at 82,570.91 while the Nifty 50 gained 113.50 points, or 0.45%, to settle at 25,195.80. The rebound follows a sharp pullback over the previous four sessions, during which both indices had shed nearly 1.7%. The market capitalization of all listed companies on the BSE increased by Rs 1.77 lakh crore to Rs 460.37 lakh crore. Sectoral Watch Shares of Sun Pharma , Trent , Tata Motors , Bajaj Finserv , Mahindra & Mahindra, and Bajaj Finance were among the top gainers on the Sensex, rising between 1% and 2.7%. All key sectoral indices ended higher on the day, with broad-based participation extending to the broader markets, both the Nifty Midcap 100 and Nifty Smallcap 100 indices advanced around 1% each. Live Events India's annual retail inflation eased to a more than six-year low of 2.10% in June, hovering near the lower end of the Reserve Bank of India's target range. The sharp decline, driven by softening food prices, has strengthened the case for potential interest rate cuts. Investors are now focused on the U.S. inflation data, due later in the day, for cues on the Federal Reserve's rate path. Among individual stocks, Sun Pharma jumped 2.7% following expectations that its newly launched anti-baldness drug, Leqselvi, in the U.S. would support sales growth. Yes Bank surged 2.4% after Bloomberg reported that Japan's Sumitomo Mitsui Financial Group is in talks to invest $1.1 billion in the lender for an additional 5% stake. On the downside, HCL Tech slipped 3.3%, making it the worst performer on both the Nifty 50 and among IT peers, after the company posted weaker-than-expected quarterly earnings and cut its full-year margin guidance. Expert Views Market sentiment is showing signs of improvement, supported by a blend of global and domestic developments and optimism is growing around the possibility of an interim trade agreement with the U.S., which could lead to a moderation in tariff-related risks, said Vinod Nair, Head of Research, Geojit Investments. Participants drew comfort from the further easing of CPI inflation, which triggered notable buying in rate-sensitive sectors in hopes of a potential rate cut, said Ajit Mishra, SVP, Research at Religare Broking. "However, continued disappointment from the IT space, following HCL Technologies' results, capped overall momentum. With the hurdle at the short-term moving average (20 DEMA) near 25,250 still intact, we suggest maintaining a cautious stance on the index and adopting a selective approach on the sectoral front," said Mishra. Global Markets World equities advanced on Tuesday as investors entered a pivotal week for U.S. earnings, inflation data, and trade developments with cautious optimism. U.S. President Donald Trump over the weekend threatened to impose 30% tariffs on the EU and Mexico from August 1, up from the 20% proposed in April. However, markets found some relief after Trump signaled openness to further negotiations before the levies take effect. MSCI's world share index edged up 0.16%, nearing last week's record highs. Europe's STOXX 600 rose 0.2%, lagging behind Asia-Pacific markets, where MSCI's ex-Japan index climbed 1%. Nasdaq futures gained 0.6% after Nvidia announced plans to resume sales of its H20 chips in China. In Asia, China's economy showed better-than-expected resilience in Q2 despite U.S. trade pressure. In commodities, gold rose 0.5% to $3,361 per ounce, while silver added 0.3% to $38.25 after hitting its highest level since September 2011. Crude Impact Oil prices held steady on Tuesday as U.S. President Donald Trump's 50-day ultimatum for Russia to end the war in Ukraine and avoid further sanctions helped ease immediate concerns over supply disruptions. Brent crude inched up 8 cents, or 0.12%, to $69.29 a barrel by 0931 GMT, while U.S. West Texas Intermediate (WTI) rose 3 cents, or 0.04%, to $67.01. Rupee vs Dollar The Indian rupee strengthened 0.2% on Tuesday to close at 85.81 against the U.S. dollar, supported by gains in most Asian currencies as the dollar weakened ahead of a key U.S. inflation report expected to offer clues on the Federal Reserve's policy path. The dollar index, which measures the greenback against six major currencies, slipped 0.11% to 97.97.
&w=3840&q=100)
Business Standard
19 hours ago
- Business Standard
HCL Tech shares slide 4% as analysts trim estimates post Q1 miss
Shares of HCL Technologies tumbled over 4 per cent on Tuesday after the technology major reported a sequential decline in net profit in the first quarter and cut its margin guidance for the full fiscal year. The IT giant's stock fell as much as 4.31 per cent during the day to ₹1,550 per share, the biggest intraday fall since April 7 this year. The stock pared gains to trade 3 per cent lower at ₹1,569.7 apiece, compared to a 0.55 per cent advance in Nifty 50 as of 11:45 AM. HCL Tech Q1FY26 results The IT services firm reported a net profit of ₹3,843 crore for the first quarter of the financial year 2026 (Q1-FY26), down 9.72 per cent year-on-year (Y-o-Y). On a sequential basis, profit was down 10.7 per cent. The company reported 3.7 per cent constant-currency (CC) revenue growth for the April-June quarter. Revenue from financial services was up 6.8 per cent, technology 13.7 per cent, and telecommunications 13 per cent. The manufacturing and life sciences verticals were down 1 per cent and 4 per cent, respectively. HCL Tech FY26 guidance HCL expects revenue to grow 3-5 per cent on a CC basis for the full year, up from 2-5 per cent it had projected in April. However, the firm cut its Ebit (earnings before interest and tax) margin guidance to 17-18 per cent from 18-19 per cent earlier. The company said the margins would be impacted due to restructuring. HCL Tech management commentary 'The macro environment remained stable from an overall perspective, with some variations across verticals, but the overall situation did not deteriorate as feared at the start of the quarter,' said C Vijayakumar, chief executive officer (CEO) and managing director, at a news conference. 'We won a large consolidation deal in financial services this quarter, which is not accounted for in the total contract value (TCV) for the first quarter,' Vijayakumar added. The value of the new deal bookings stood at $1.81 billion. Analysts on HCL results Nuvama Institutional Equities said that weak margins in Q1-FY26 and a guidance cut have left HCLTech with almost no earnings per share (EPS) growth expected for FY26. "While we continue to favour its strong revenue growth, making it the fastest-growing among the top five IT firms, earnings have been impacted by lower margin expectations." Nuvama downgraded the stock to 'hold' and said that it now trades at a slight premium to TCS and Infosys, limiting further upside. Emkay Global noted that HCLTech's Q1FY26 operating performance was weaker than expected, primarily due to a margin miss, although revenue was in line. The brokerage lowered its FY26-28 earnings per share (EPS) estimates by 3-7 per cent, factoring in the Q1 results and the margin guidance cut. It retained 'Reduce' rating and revised the target price by around 5 per cent to ₹1,660. Nomura cut its FY26-27 EPS estimates by around 2-5 per cent and slashed the target price to ₹1,810 (from ₹1,840 earlier). "We expect the street to look past the near-term margin miss, as margins are likely to recover in FY27, and instead focus on HCLTech's continued revenue outperformance."
